121 related articles for article (PubMed ID: 8877583)
1. N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation.
Chirkov YY; Horowitz JD
J Cardiovasc Pharmacol; 1996 Sep; 28(3):375-80. PubMed ID: 8877583
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris.
Chirkov YY; Naujalis JI; Sage RE; Horowitz JD
J Cardiovasc Pharmacol; 1993 Mar; 21(3):384-9. PubMed ID: 7681498
[TBL] [Abstract][Full Text] [Related]
3. Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Am J Cardiol; 1997 Jul; 80(2):128-31. PubMed ID: 9230146
[TBL] [Abstract][Full Text] [Related]
4. Nitrate resistance in platelets from patients with stable angina pectoris.
Chirkov YY; Holmes AS; Chirkova LP; Horowitz JD
Circulation; 1999 Jul; 100(2):129-34. PubMed ID: 10402441
[TBL] [Abstract][Full Text] [Related]
5. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets.
Chirkov YY; Holmes AS; Willoughby SR; Stewart S; Wuttke RD; Sage PR; Horowitz JD
J Am Coll Cardiol; 2001 Jun; 37(7):1851-7. PubMed ID: 11401122
[TBL] [Abstract][Full Text] [Related]
6. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Smith TW; Antman EM
Circulation; 1988 Apr; 77(4):787-94. PubMed ID: 3127076
[TBL] [Abstract][Full Text] [Related]
7. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
[TBL] [Abstract][Full Text] [Related]
8. Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction.
Horowitz JD
Am J Med; 1991 Sep; 91(3C):113S-117S. PubMed ID: 1928201
[TBL] [Abstract][Full Text] [Related]
9. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats.
Booth BP; Jacob S; Bauer JA; Fung HL
J Cardiovasc Pharmacol; 1996 Sep; 28(3):432-8. PubMed ID: 8877591
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
Amano M; Takahashi M; Kosaka T; Kinoshita M
J Cardiovasc Pharmacol; 1994 Dec; 24(6):860-6. PubMed ID: 7898066
[TBL] [Abstract][Full Text] [Related]
11. Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Antman EM; Smith TW
Eur Heart J; 1988 Jan; 9 Suppl A():95-100. PubMed ID: 3137075
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
Pizzulli L; Hagendorff A; Zirbes M; Jung W; Lüderitz B
Am J Cardiol; 1997 Jan; 79(1):28-33. PubMed ID: 9024731
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effects of a novel antianginal agent, nicorandil.
Jaraki O; Strauss WE; Francis S; Loscalzo J; Stamler JS
J Cardiovasc Pharmacol; 1994 Jan; 23(1):24-30. PubMed ID: 7511731
[TBL] [Abstract][Full Text] [Related]
14. Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione.
Haramaki N; Ikeda H; Takajo Y; Katoh A; Kanaya S; Shintani S; Haramaki R; Murohara T; Imaizumi T
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1852-6. PubMed ID: 11701477
[TBL] [Abstract][Full Text] [Related]
15. Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects.
Chirkov YY; Naujalis JI; Barber S; Sage RE; Gove DW; Brealey JK; Horowitz JD
Am J Cardiol; 1992 Sep; 70(7):802-6. PubMed ID: 1519534
[TBL] [Abstract][Full Text] [Related]
16. Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study.
Karlberg KE; Saldeen T; Wallin R; Henriksson P; Nyquist O; Sylvén C
J Intern Med; 1998 Jan; 243(1):25-31. PubMed ID: 9487328
[TBL] [Abstract][Full Text] [Related]
17. Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance.
Holmes AS; Chirkov YY; Willoughby SR; Poropat S; Pereira J; Horowitz JD
Br J Clin Pharmacol; 2005 Oct; 60(4):355-63. PubMed ID: 16187967
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.
Horowitz JD; Antman EM; Lorell BH; Barry WH; Smith TW
Circulation; 1983 Dec; 68(6):1247-53. PubMed ID: 6139183
[TBL] [Abstract][Full Text] [Related]
19. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia.
Aoki H; Inoue M; Mizobe T; Harada M; Imai H; Kobayashi A
Br J Anaesth; 1997 Oct; 79(4):476-81. PubMed ID: 9389267
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of the nitrovasodilators. Antianginal, antihypertensive, and antiplatelet actions.
Gold ME
Nurs Clin North Am; 1991 Jun; 26(2):437-50. PubMed ID: 1904576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
